7Baggers
Quarterly
Annual
    Unit: USD2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-09-30 2022-06-30 2022-03-31 2021-03-31 2020-12-31 2020-09-30 2020-06-30 
      
    		            
      cash flows from operating activities
    		            
      net income
    		-4,612,000 -9,306,000 -2,859,000 -14,519,000 -2,300,000 -3,116,000 -4,477,000 -4,570,000 -20,673,217 -3,853,396 -5,766,482 -10,462,030 
      adjustments to reconcile net income to net cash from operating activities:
    		            
      stock-based compensation
    		274,000 268,000 133,000 132,000 181,000 480,000 1,448,000 1,083,000 3,463,003 1,613,339 970,432 8,079,223 
      depreciation and amortization
    		212,000 191,000 170,000 190,000 182,000 126,000 127,000 107,000 46,128 21,428 20,584 14,697 
      loss on extinguishment of warrant liability
    		 0 0 0 504,000        
      change in fair value of warrant liability
    		23,000 -34,000 -2,688,000 -2,130,000 -5,606,000    1,023,188 598,899 861,365 -122,909 
      gain on issuance of convertible note
    		 0   -64,000        
      amortization of debt discount
    		    374,000    457,671 266,361 937,786 1,051,698 
      change in fair value of notes
    		 0 40,000 6,883,000 117,000        
      amortization of deferred debt issuance costs
    		944,000 2,541,000 2,751,000 2,414,000 1,635,000        
      amortization of right-of-use assets
    		168,000            
      other incomes
    		 161,000 -808,000 69,000 1,206,000        
      changes in operating assets and liabilities:
    		            
      prepaid and other assets
    		-111,000 -75,000 150,000 147,000 -161,000 389,000 90,000 -87,000     
      accounts receivable
    		-693,000            
      note receivables
    		-576,000            
      deferred revenue
    		1,260,000            
      accounts payable
    		797,000 521,000 -154,000 761,000 125,000 -3,000       
      accrued expenses
    		-228,000 1,015,000 167,000 178,000 -920,000 17,000 26,000 -208,000 -145,417 113,578 -332,560 -189,905 
      lease liabilities
    		-171,000            
      warranty customer liability
    		36,000            
      net cash from operating activities
    		-2,677,000 -4,351,000 -3,421,000 -3,660,000 -4,728,000 -2,106,000 -2,391,000 -3,552,000 -2,978,970 -811,181 -1,507,576 -1,286,656 
      capex
    		0 0 0 0 0 0 0 0 0 0 0 0 
      free cash flows
    		-2,677,000 -4,351,000 -3,421,000 -3,660,000 -4,728,000 -2,106,000 -2,391,000 -3,552,000 -2,978,970 -811,181 -1,507,576 -1,286,656 
      cash flows from investing activities
    		            
      cash paid for acquisition of amerigen 7
    		 0 -1,000 1,000 -645,000        
      purchase of equipment
    		-63,000 -1,089,000 -377,000 -272,000 -435,000 -20,000 -200,000 -58,000 -76,893 -52,913   
      net cash from investing activities
    		-63,000 -1,089,000 -378,000 -271,000 -1,080,000 -20,000 -254,000 -65,000 -1,526,893 -77,913   
      cash flows from financing activities
    		            
      proceeds from the exercise of warrants
    		 0 1,000 -1,000 2,062,000        
      proceeds from the issuance of common stock and warrants, net of fees
    		            
      proceeds from the issuance of common stock / at-the-market offering, net of offering costs
    		588,000            
      proceeds from issuance of notes in connection with line of credit
    		            
      proceeds from issuance of january promissory notes, net of fees paid
    		   387,000 970,000        
      repayment of notes payable
    		-8,000 0 -351,000 -1,983,000 -14,000    0 0   
      proceeds from the issuance of common stock in connection with equity line of credit, net of offering costs
    		1,391,000 0           
      net cash from financing activities
    		1,971,000 4,441,000 5,819,000 1,829,000 7,125,000 1,484,000   19,767,178 323,779 1,545,700 1,830,200 
      net increase / decrease in cash
    		-769,000 -997,000 2,020,000 -2,102,000 1,317,000        
      cash — beginning of period
    		1,059,000 0 0 0 821,000 0 0 6,130,000  0 0 48,307 
      cash — end of period
    		290,000 -997,000 2,020,000 -2,102,000 2,138,000 -642,000 -1,529,000 2,513,000  -565,315 9,073 591,851 
      supplemental disclosure of non-cash investing and financing activities:
    		            
      issuance of series e preferred stock in connection with line of credit
    		 0           
      issuance of common stock in connection with conversion of notes
    		 -516,000 2,165,000 0 516,000     0 2,342,162 2,151,461 
      commitment to issue shares of common stock in connection with march waiver agreement
    		    298,000        
      deemed dividend for repricing of series d preferred stock
    		   0 6,000        
      unpaid equipment included in accounts payable
    		  -69,000 -64,000 156,000 374,000 108,000 4,000     
      supplemental cash flow information
    		            
      cash paid for interest
    		 5,000 1,000 0 8,000 0 0 3,000 2,448 4,061 181 55,959 
      series a preferred stock
    		3,146,000     0 0 188,311,000     
      series b preferred stock
    		33,883,000     0 0 2,019,038,000     
      series c preferred stock
    		9,346,000     0 0 560,757,000     
      series d preferred stock
    		            
      series e preferred stock
    		            
      convertible notes
    		         -5,536,997 -2,342,163 8,417,824 
      series f preferred stock
    		501,579,000            
      series f-1 preferred stock
    		72,631,000            
      series f-2 preferred stock
    		124,946,000            
      warrants to purchase common stock
    		2,470,078,000     1,176,602,000 0 4,725,177,000  -4,273,483 795,800 5,764,356 
      warrants to purchase series e preferred stock
    		750,000,000            
      options to purchase common stock
    		632,779,000     767,500,000 -1,496,113,000 10,567,099,000  -6,066,603 2,433,932 14,050,167 
      unvested restricted stock units
    		1,124,527,000     370,833,000 -1,745,276,000 2,261,905,000     
      commitment shares
    		212,890,000            
      total
    		5,935,805,000            
      change in fair value of liability
    		            
      loss on extinguishment of debt
    		 0 0      13,804,849 255,046 179,400 18,200 
      amortization of right of use assets
    		   912,000 133,000 126,000 121,000 118,000     
      impairment of goodwill
    		            
      intangible asset impairment
    		            
      loss on lease termination
    		            
      loss on disposal of equipment
    		 -236,000 145,000   0 0 52,000     
      lease liability
    		   -967,000 -134,000 -125,000 -128,000 -15,000     
      purchase of patents
    		     0 -54,000 -7,000     
      proceeds from the issuance of common stock / at-the-market offering
    		 4,441,000 1,759,000 0 2,198,000 672,000       
      proceeds from the issuance of notes in connection with line of credit
    		 0 0 350,000 2,000,000        
      offering costs for the issuance of common stock / at-the-market offering
    		 0 -79,000 0 -91,000 -24,000       
      proceeds from issuance of senior secured convertible notes and common stock warrants
    		        0 626,000 0 2,050,000 
      proceeds from issuance of series d preferred stock and warrants, net of fees
    		            
      proceeds from issuance of series f-1 preferred stock
    		 0 0          
      proceeds from issuance of series f-2 preferred stock
    		 0 0          
      issuance of common stock in connection with equity line of credit
    		 0           
      issuance of series f preferred stock in connection with exchange of series d preferred stock
    		 0 0          
      issuance of common stock in connection with senior secured notes settlement
    		 0           
      issuance of common stock warrants in connection with sloc
    		     0 0 223,000     
      commitment to issue shares of common stock connection with demand notes
    		            
      conversion of senior secured notes into series f preferred stock
    		            
      issuance of common stock warrants in connection with consideration payable
    		            
      acquisitions of property and equipment included in liabilities
    		            
      right-of-use assets obtained in exchange for operating lease liabilities
    		            
      reduction of right of use asset and operating lease liability due to early lease termination
    		            
      ●
    		            
      change in fair value of derivative liability
    		            
      proceeds from a deposit for series d preferred stock
    		            
      proceeds from issuance of senior secured notes, net of fees paid
    		            
      conversion of senior secured notes into series f preferred stock in connection with exchange agreements
    		            
      commitment to issue shares of common stock in connection with demand notes
    		  0          
      issuance of series e preferred stock in connection with loc
    		   5,593,000 4,350,000        
      issuance of common stock to consultants
    		        3,326 20,000 0 282,109 
      gain on forgiveness of ppp loan
    		            
      proceeds from exercise of stock options
    		            
      net decrease in cash
    		            
      cash — beginning of year
    		            
      cash — end of year
    		            
      numerator
    		            
      cumulative dividends on series d preferred stock
    		            
      numerator for basic and diluted net income per share
    		            
      denominator
    		            
      weighted-average common shares outstanding
    		            
      less: weighted-average shares subject to repurchase
    		            
      denominator for basic and diluted net income per share
    		            
      shares used to compute pro forma net income per share, basic and diluted
    		            
      net income per share
    		            
      basic and diluted
    		            
      loss on exchange of notes payable for common stock and warrants
    		        5,836 0   
      accrued interest
    		        71,247 70,459 151,837 126,556 
      proceeds from the exercise of common stock warrants
    		            
      proceeds from ppp loan
    		        233,300 0 0 205,200 
      repayment of related party non interest bearing advance
    		            
      net increase increase in cash
    		     -642,000       
      issuance of common stock and preferred stock in connection with conversion of notes
    		            
      repurchase beneficial conversion feature in connection with conversion of notes payable
    		            
      reclassification of warrant liabilities
    		        3,565,603    
      issuance of common stock warrants in connection with note exchange agreements
    		            
      proceeds from the issuance of common stock, net of fees
    		         0   
      proceeds from a deposit for the series d preferred stock
    		            
      cash paid income taxes
    		            
      unvested restricted stock awards
    		          -749,997 3,000,012 
      (gain) loss on extinguishment of debt
    		            
      account payable
    		       -32,000 -922,471 231,601 600 -112,134 
      net increase in cash
    		       -3,617,000   9,073 543,544 
      non-cash expenses for placement agent
    		        0 0   
      proceeds from the exercise of stock options
    		            
      repayment of senior secured promissory note
    		        0 0 0 -200,000 
      common stock repurchased and subsequently canceled
    		        0 -225,000 0 -225,000 
      unpaid research and development license included in accounts payable
    		         0 -25,000 100,000 
      beneficial conversion feature in connection with notes payable
    		        0 0 0 618,657 
      issuance of common stock in connection with notes payable
    		        0 203,500 179,400 750,750 
      issuance of common stock in satisfaction of accounts payable
    		        0 0 0 121,835 
      issuance of common stock and warrants
    		            
      deferred offering costs
    		            
      bad debt expense
    		            
      proceeds from related party non-interest bearing advance
    		        0    
      proceed from the exercise of common stock warrants
    		            
      proceeds from notes payable
    		            
      repayment of related party non-interest bearing advance
    		        -25,000    
      unpaid deferred offering costs
    		            
      repurchased beneficial conversion feature in connection with conversion of notes payable
    		            
      canceled restricted stock awards
    		        6    
      issuance of common stock warrants in connection with notes payable
    		            
      exercise of stock options
    		            
      issuance of common stock and warrants in connection with cancellation of consulting agreement
    		            
      chang in fair value of derivative liability
    		            
      prepaid and other current assets
    		         -109,725 -84,400 5,392 
      purchase of research and development license
    		            
      payment of financing costs
    		            
      change in cash overdraft
    		            
      exercise of common stock warrants
    		         -19 0 29 
      issuance of common stock warrants
    		            
      proceeds from related party
    		            
      loss on conversion of notes
    		           22,447 
      due to related parties
    		            
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.